The View Hospital becomes first in Qatar to offer 3D CT Gastric Volume Study for bariatric patients
Doha
The View Hospital, in affiliation with Cedars-Sinai, has become the first hospital in Qatar to offer the 3D CT Gastric Volume Study, an advanced diagnostic imaging service that gives physicians a clearer view of post-surgical anatomy in bariatric patients.
The launch of the service marks a milestone not only for the hospital but for the country's evolving landscape of precision medicine. Designed specifically for individuals who have undergone bariatric procedures, the 3D CT Gastric Volume Study delivers highly detailed, three-dimensional images that accurately assess the size and shape of the remaining stomach. The technology helps clinicians detect structural abnormalities, track patient progress, and anticipate potential complications, all with exceptional accuracy and speed.
'For many patients, bariatric surgery is a turning point in their health journey,' said Dr Jassim Fakhro, senior consultant in Metabolic and Bariatric Surgery and Medical Director of Qatari Physicians at The View Hospital. 'But it doesn't end in the operating room. Ongoing monitoring is key, and with this technology, we can now offer unmatched insight and support as patients work toward a healthier future.'
This imaging advancement couldn't come at a more crucial time. As rates of obesity and metabolic disease rise across the region, bariatric surgery has emerged as a powerful tool for intervention. But surgery alone isn't enough - what follows is a complex physiological transition that demands thoughtful, individualized follow-up care.
That's where the 3D CT Gastric Volume Study makes its impact. By visualising the internal anatomy in such detail, physicians can make data-driven decisions tailored to each patient's unique post-surgical profile. Whether it's adjusting dietary recommendations, identifying mechanical issues, or flagging early signs of nutritional compromise, this diagnostic innovation offers a more complete picture and a more proactive path forward.
Moreover, this technology plays a pivotal role in planning revisional bariatric surgeries, particularly in cases of weight regain or severe GERD (gastroesophageal reflux disease) after the initial procedure. The precise anatomical data provided by the 3D imaging enables surgeons to better evaluate the structural causes behind such complications and tailor surgical interventions, accordingly, improving outcomes and patient safety.
'At The View Hospital, we are committed to healthcare innovation and advancing academic care,' said Dr Fatih Mehmet Gul, CEO of The View Hospital.
'The launch of Qatar's first 3D CT Gastric Volume Study for bariatric patients reflects our medical expertise and dedication to providing precise, personalized treatment through cutting-edge technologies.'
With this latest addition, The View Hospital further strengthens its position as a leader in advanced, patient-centered care. By combining innovative technology with a deep commitment to personalized medicine, the hospital continues to raise the bar for what modern healthcare should look likein Qatar and across the region.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Qatar Tribune
2 days ago
- Qatar Tribune
Sidra Medicine contributes to breakthrough tool for early detection of Type 1 diabetes
Tribune News Network Doha Sidra Medicine, a member of Qatar Foundation, has helped develop an artificial intelligence (AI) powered tool that predicts the risk of developing Type 1 Diabetes (T1D), enabling earlier diagnosis and more targeted care. The tool uses microRNA signals in the blood to detect early biological changes linked to the disease. Published in Nature Medicine, the study titled 'A microRNA-based dynamic risk score for type 1 diabetes' introduces a dynamic risk score based on microRNAs, which are tiny molecules in the blood that reflect changes in the body, including early stress in insulin-producing Beta cells. By analysing data from over 2,800 participants, the researchers found that these molecular signals could identify individuals at high risk of developing T1D long before symptoms appear. Dr. Ammira Akil, principal investigator at Sidra Medicine and director of the Metabolic and Mendelian Disorders Translational Programme, who designed the study, said: 'This study marks a significant advancement in the way we understand and manage autoimmune diseases like Type 1 Diabetes. By combining microRNA profiling with artificial intelligence, we have developed a predictive risk score that can help identify individuals at highest risk, optimise treatment decisions and determine when to intervene. It is a powerful example of how AI and Machine Learning are transforming precision medicine into real-world clinical impact.' Sidra Medicine's contribution to the study was led by the Mendelian and Metabolic Translational Research Programme under the Precision Genomics and Translational Omics Lab. The team played a keyrole in the early laboratory work on primary human insulin-producing cells and conducted critical analyses that helped with the development and validation of the clinical risk score. The study findings complement ongoing efforts at Sidra Medicine, including the DANNA1 cohort, a local foundational population-based registry of individuals with T1D in Qatar that underpin the upcoming national screening programme for early detection and prevention of Type 1 Diabetes. Prof. Khalid Fakhro, chief research officer and chair of the Precision Medicine Programme at Sidra Medicine, said: 'The study findings demonstrate that the microRNA-based dynamic risk score can accurately differentiate between individuals with and without Type 1 Diabetes. It also predicts who may become insulin dependent after an islet cell transplant and identifies patients likely to respond to specific therapies - insights that current clinical markers cannot provide. 'Importantly, this assessment is achievable through a simple, minimally invasive blood test, making it highly promising for routine clinical use. The study also reflects our ongoing commitment to advancing the use of artificial intelligence as a powerful tool to drive earlier diagnosis, more precise treatments, and safer outcomes for patients.' The next phase of the research will focus on validating the findings across broader and more diverse populations and assessing the integration of the dynamic risk score into clinical trials and early intervention strategies. Sidra Medicine will continue to support these efforts through its research programmes and ongoing collaborations. The groundbreaking study was made possible through a multinational collaboration involving experts from Sidra Medicine, Breakthrough T1D, the University of Western Sydney, and the PREDICT T1D Study Group.
Qatar Tribune
2 days ago
- Qatar Tribune
QFFD signs deals worth QR1.92 billion to support humanitarian, development drives across world
QNA Doha Qatar Fund for Development (QFFD) has signed 16 strategic agreements worth QR1.92 billion to support a wide range of humanitarian and development initiatives for more than 17 million individuals worldwide. The signing ceremony was attended by Chairman of the Board of Directors of QFFD HE Sheikh Thani bin Hamad bin Khalifa Al Thani, Minister of State for International Cooperation and Vice-Chairperson of the Board of Directors of QFFD HE Maryam bint Ali bin Nasser Al Misnad, Deputy Minister of Agriculture and Food Security of Sierra Leone Dr. Theresa Tenneh Dick, a number of officials from Bosnia and Herzegovina, representatives of a number of embassies in Qatar, and representatives of United Nations organisations. The signing ceremony marked a major milestone in the State's global efforts to promote sustainable development and humanitarian aid initiatives. Al Misnad said, 'What Qatar is doing today through the Qatar Development Fund is not just an international commitment, but rather a reflection of our deep human values. We believe that investing in people is a real investment, and these agreements represent a concrete step towards building more stable and just societies and changing the lives of millions for the better. Qatar will remain an active partner in the global development process, placing people at the heart of its priorities.' At the ceremony, the Fund signed deals with prominent local partners such as Qatar Foundation in partnership with the American University of Afghanistan in Qatar, Qatar Charity, Education Above All Foundation, and Qatar Red Crescent Society. International agreements were signed with the governments of Bosnia and Herzegovina and Sierra Leone, and the announcement of a memorandum of understanding with Rwanda was made. With Qatar Charity, four agreements were signed targeting 1,307,292 beneficiaries that included a grant agreement for emergency assistance following the flood crisis in the Republic of Niger, a grant agreement to support healthcare services at Bab Al-Hawa Hospital in Syria, a grant for Rohingya refugees in Malaysia, an agreement for the first response project to emergency cases in the northern parts of Syria. With Education Above All Foundation, QFFD signed two agreements targeting more than 15 million children and youth that included a Strategic Framework Agreement and a grant agreement to support a scholarship programme for Afghan students. With Qatar Red Crescent Society, six agreements were signed targeting more than 294,487 beneficiaries, including a grant agreement for emergency support to the White Helmets' new phase for Syria, a project agreement to support the cardiac centre at Indira Gandhi Children's Hospital in the capital of Afghanistan, Kabul, a grant agreement for humanitarian aid in Syria, a grant agreement to support the expansion of the children's playground at the Qatari clinics in Zaatari camp in Jordan, a grant agreement for the 'Good Caravan' project for children and adults in Guyana, and a grant agreement for emergency relief following the fire tragedy at the central local market in the Gabu region in Guinea-Bissau to support affected individuals and meet their basic humanitarian needs. Additionally, an agreement for the temporary hosting of the American University of Afghanistan in Qatar, in collaboration with Qatar Foundation, with the aim of benefitting 73 students, has been signed. For Government-Level memoranda, QFFD has signed a memorandum of understanding regarding the rehabilitation of water networks in three municipalities with Bosnia and Herzegovina that is set to benefit 6,000 beneficiaries, a memorandum of understanding to support the national 'Zero-Out-of-School Children' programme in Rwanda to benefit 177,119 child, and a memorandum of understanding in partnership with the Ministry of Agriculture and Food Security for the African Multiplication Initiative in Sierra Leone to benefit 530,152 beneficiaries. This latest round of agreements reflects the QFFD's ongoing commitment to achieving the Sustainable Development Goals (SDGs) and advancing the Qatar National Vision 2030. It also reinforces the State's dedication to sharing its development expertise with vulnerable communities worldwide.
Qatar Tribune
3 days ago
- Qatar Tribune
Referral process monitored for equitable patient distribution
The referral process is closely monitored to ensure equitable distribution of patients and the efficient use of healthcare resources. Referrals are facilitated through a secure electronic platform, ensuring confidentiality and seamless data exchange with the private hospitals. Eligible patients are contacted to obtain their consent before the referral is initiated. Once consent is given, the referral is transmitted securely via the platform. Additionally, selected physicians at the participating private hospitals have been granted limited, secure access to patients' medical files at HMC to support continuity of care. Patients may also request their medical reports from HMC when needed to assist in treatment decisions at the referral facility. Al Naimi highlighted that this referral initiative initially began with The View Hospital and has now expanded to include five private hospitals. Al Naimi expressed confidence that the program will significantly enhance the treatment experience for Qatari citizens.
